RE: My take on AGM So, Beech. Do we still have a partnership with Endo? The contract stipulates that all NR concerning the trial has to be from Endo. BNC came out and made the NR. Does that mean the contract is void and we are not bound anymore?
You talk about "other pharma". Is that for new MCC plateform applications? What are they?
Is there any time line on "light at the end of the tunnel"? How do they plan to satisfy FDA's requirements?
What does traction for Econiche mean? Mandate or subsidy?
Thanks.